Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Other neoplasm 1

Conditions

Squamous Cell Carcinoma of Head and Neck 4Carcinoma, Non-Small-Cell Lung 4Adenocarcinoma of Lung 4Lung Neoplasms 3Esophageal Neoplasms 3Mouth Neoplasms 2Head and Neck Neoplasms 2Barrett Esophagus 2Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Skin Neoplasms 1Salivary Gland Neoplasms 1Precancerous Conditions 1Oropharyngeal Neoplasms 1Laryngeal Neoplasms 1Esthesioneuroblastoma, Olfactory 1Carcinoma, Basal Cell 1Adenocarcinoma, Follicular 1Adenocarcinoma Of Esophagus 1

Interventions

Cisplatin 109Radiotherapy 100Fluorouracil 90Paclitaxel 75Oxaliplatin 63Docetaxel 56Carboplatin 55Irinotecan 41Esophagectomy 41Leucovorin 40Capecitabine 39Radiation 36Surgical Procedures, Operative 35Drug Therapy 31Neoadjuvant Therapy 25Chemoradiotherapy 18Cetuximab 18S 1 (combination) 17pembrolizumab 16camrelizumab 16Nivolumab 15Magnetic Resonance Spectroscopy 15Bevacizumab 15Blood Specimen Collection 14Surveys and Questionnaires 12Radiotherapy, Intensity-Modulated 12Immunotherapy 11Epirubicin 11Biopsy 11Trastuzumab 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Esophageal Neoplasms × 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a × Clear all
NCT00281736 2014-01-03

Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer

Roswell Park Cancer Institute

Phase 2 Completed
60 enrolled
GastrointestinalOther neoplasm

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Precancerous Conditions

NCT01035437 2012-07-02

Study for Determination of Feasibility and Toxicity of Pre-Treatment With HPPH (2-1[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a) Photodynamic Therapy Prior to Chemoradiation in Non-Operable Patients With Obstructive Esophageal Cancer

Roswell Park Cancer Institute

Phase NA Withdrawn
Gastrointestinal

Esophageal Neoplasms

NCT00060268 2011-03-09

Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors

Roswell Park Cancer Institute

Phase 1/2 Completed
11 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡